Hycells New Product | IFN-γ ELISPOT Assay Kit
Release Date:
2025-07-07 15:24
Principle of ELISPOT Technology
Enzyme-linked immunospot assay: The term “enzyme-linked” carries the same meaning as in ELISA, referring to an immunoassay that relies on enzymatic reaction amplification. As with ELISA, the antibodies in ELISPOT are immobilized (coated) onto a solid support; however, whereas ELISA antibodies capture target proteins that are already present and uniformly distributed in the sample solution, ELISPOT antibodies capture proteins freshly secreted by cells in response to dynamic stimulation. In ELISA, the detection signal is manifested as a colored solution, whereas in ELISPOT it appears as colored spots deposited on the solid substrate. Both ELISPOT and ELISA are based on the sandwich immunoassay principle, but ELISPOT further incorporates cell culture techniques. While ELISA provides quantitative measurement of the concentration of a target protein in the sample solution, ELISPOT offers a dynamic assessment of the immune status of live cells within the sample.
ELISPOT (enzyme-linked immunospot assay) enables the quantitative measurement of cytokine secretion by individual cells. As one of the most sensitive molecular detection methods available today, ELISPOT exhibits a sensitivity 20 to 200 times greater than that of ELISA. Because the analyte of interest binds immediately to the capture antibody upon secretion, it is protected from degradation by binding proteins and proteases. Its advantages—including high sensitivity, high reliability, high-throughput capability, and the preservation of immune function—make ELISPOT a practical tool for studying small populations of living cells. It finds broad applications in basic immunological research, vaccine development, and immunogenicity studies, among other fields. In particular, the IFN-γ ELISPOT assay has become the “gold standard” for evaluating cell-mediated immune responses induced by vaccines. By measuring IFN-γ levels, one can indirectly assess the activity of helper T cells, which is critical for understanding immune responses.
Relying on its extensive proprietary cell bank and ELISPOT R&D technology service platform, Hycells has launched the IFN-γ ELISA Spot Assay Kit (Catalog No.: DCT01004-kit). This product utilizes a pre-coated ELISPOT assay kit, reducing the assay duration from 3 days to 2 days, significantly streamlining sterile-handling procedures, alleviating the workload of laboratory personnel, and minimizing the risk of contamination. As a result, researchers can perform complex ELISPOT assays with ease and high efficiency.
Product Overview of the IFN-γ ELISpot Assay Kit
Kit Components
Product Advantages
End-to-end localization of the assay kit: the original research antibodies are sourced from in-house screening, and both the coating process and coating reagents have been fully developed and localized.
Wide sample applicability: Suitable for the in vitro quantitative determination of interferon-γ levels in human serum, plasma, cell culture supernatants, or other relevant biological fluids.
High specificity: Utilizes a sandwich ELISA format, making it suitable for the analysis of complex samples.
High sensitivity: detection sensitivity is consistently in the single-digit range;
Convenient operation: the sample does not require any special purification treatment;
Good reproducibility: Repeated experiments demonstrate low intra-assay and inter-assay coefficients of variation, indicating excellent stability.
Product Usage and Operation Procedure
Day 1: Seed cells, add stimulants or test samples, and perform culture procedures (with strict adherence to aseptic technique).
1. Activation of the pre-coated plate: Add 200 μL of serum-free medium or RPMI-1640 medium to each well, incubate at room temperature for 5–10 minutes, then carefully aspirate the liquid.
2. Add cell suspension: Add the cell suspension adjusted to the desired concentration to each experimental well.
3. Add the stimulant: add PHA diluted 1:1000 to the culture medium.
4. Add the samples to be tested: According to the experimental requirements, add the samples to be tested that have been diluted in culture medium. Use the same volume of culture medium for the blank/negative control.
5. Incubation: After all samples and stimulants have been added, securely seal the plate with its lid. Incubate in a 37°C, 5% CO2 incubator for 16–20 hours.
Day 2: Post-Culturing Assay Procedures
1. Lyse the cells: Discard the cells and culture medium from the wells. Add 200 μL per well of ice-cold deionized water, and incubate at 4°C for 5–10 minutes to induce hypotonic lysis.
2. Plate washing: Discard the liquid from the wells, then wash 5 times with 1× PBS at 200 μL per well. For the final wash, blot dry on absorbent paper.
3. Antibody incubation: Dilute the biotinylated antibody working solution in PBS containing 1.0% BSA, and add 100 μL per well to each experimental well. Incubate at 37°C for 1 hour.
4. Plate washing: Discard the liquid from the wells, then wash 5 times with 1× PBS at 200 μL per well. For the final wash, blot dry on absorbent paper.
5. Streptavidin-HRP Incubation: Add 100 μL per well of the diluted Streptavidin-HRP working solution to each assay well. Incubate at 37°C for 1 hour.
6. Plate washing: Discard the liquid from the wells, then wash 5 times with 1× PBS at 200 μL per well. For the final wash, blot dry on absorbent paper.
7. Color Development: Add 100 μL per well of the TMB chromogenic substrate working solution to each assay well. Incubate at room temperature in the dark for 5–15 minutes.
8. Stop the color development: Decant the liquid from the wells, remove the plate base, and wash the plate 3–5 times on both sides and on the base with deionized water to stop the color development. Place the plate in a cool, shaded area at room temperature and allow it to air-dry naturally before replacing the base.
9. Count spots on the ELISPOT plate, record various spot parameters, and perform statistical analysis.
IFN-γ ELISpot Assay Kit Verification Data Display
Hycells’ ELISPOT assay results demonstrate significantly higher spot counts compared with imported competing products, reflecting superior assay precision and accuracy.
Reproducibility: PBMCs + PHA (1.0 μg/mL), incubated for 16 hours, with 11 replicates.
Related News
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how He Yousheng proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Recently, the research team led by Researcher Bian Yingjie at the Guangzhou National Laboratory, in collaboration with partners from Sun Yat-sen University, published a study titled “Iron overload in the tumor microenvironment induces CD8⁺ T cell ferroptosis and dysfunction” in the internationally renowned academic journal Nature Communications.
Hycells Recruitment | Never Stop Exploring, Never Stop Innovating
The company consistently upholds its core values of “people‑centricity, quality first, and innovation as the foundation,” remains driven by technological innovation, and sets new industry benchmarks for domestic innovation, thereby laying a solid foundation for the development and global advancement of China’s innovative pharmaceutical sector.
The HiXpan® NK Serum-Free Culture Kit, Version 3.0, is manufactured in strict compliance with GMP standards, and its production system fully adheres to relevant guidelines and regulations, including the “818 Requirements,” positioning it for pharmaceutical‑grade manufacturing and applications.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board